Investors Research Corp - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 107 filers reported holding HOMOLOGY MEDICINES INC in Q4 2020. The put-call ratio across all filers is 6.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
Investors Research Corp ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q3 2023$187
+31.7%
1600.0%0.00%
Q2 2023$142
-13.9%
1600.0%0.00%
Q1 2023$165
-18.3%
1600.0%0.00%
Q4 2022$2021600.0%0.00%
Q3 2022$01600.0%0.00%
Q2 2022$01600.0%0.00%
Q1 2022$0
-100.0%
1600.0%0.00%
Q4 2021$1,0000.0%1600.0%0.00%
Q3 2021$1,0000.0%1600.0%0.00%
Q2 2021$1,000
-50.0%
1600.0%0.00%
-100.0%
Q1 2021$2,0000.0%1600.0%0.00%0.0%
Q4 2020$2,0000.0%1600.0%0.00%0.0%
Q3 2020$2,0001600.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q4 2020
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$5,307,0251.53%
Western Standard LLC 250,060$292,5700.26%
OUP Management Co., LLC 64,000$74,8800.17%
Vivo Capital, LLC 370,068$432,9800.05%
Temasek Holdings (Private) Ltd 5,650,996$6,611,6650.04%
GEORGE KAISER FAMILY FOUNDATION 39,320$46,0040.01%
American Investment Services, Inc. 36,955$43,2380.01%
RBF Capital, LLC 58,700$68,6790.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 185,100$216,5670.01%
XTX Topco Ltd 21,188$24,7900.00%
View complete list of HOMOLOGY MEDICINES INC shareholders